Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Aerosol: SOP for Revalidating Processes After Changes – V 2.0

Posted on By

Aerosol: SOP for Revalidating Processes After Changes – V 2.0

SOP for Revalidating Processes After Changes

Department Aerosol
SOP No. SOP/Aerosol/120/2025
Supersedes SOP/Aerosol/120/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for revalidating aerosol manufacturing processes after any significant changes to the process, equipment, formulation, or materials. The objective is to ensure that after any modifications, the process still consistently produces products that meet all predefined quality specifications and regulatory requirements. Revalidation helps to confirm that any changes do not negatively impact the process’s ability to consistently meet the required product standards.

2. Scope

This SOP applies to all aerosol manufacturing processes at [Company Name] that require revalidation after changes. These changes may include modifications to equipment, materials, formulations, process parameters, or any other changes that could impact product quality. The SOP also covers revalidation of processes after corrective actions or improvements have been made to address issues observed in earlier batches.

3. Responsibilities

  • Validation Team: Responsible for overseeing the revalidation process, including evaluating the need for revalidation, preparing validation protocols, and analyzing results after changes are made.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the revalidation protocol, ensuring compliance with GMP and regulatory guidelines, and verifying that revalidation results meet quality and
safety standards.
  • Production Team: Responsible for executing the revalidation runs according to the revalidation protocol, documenting the results, and reporting any deviations or issues during production.
  • Regulatory Affairs Team: Ensures that the revalidation process complies with all applicable regulatory standards and guidelines and is properly documented for audits and inspections.
  • 4. Accountability

    The Manufacturing Manager is accountable for ensuring that the revalidation process is properly executed according to this SOP. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

    5. Procedure

    5.1. Identifying the Need for Revalidation

    1. Revalidation should be initiated whenever a change is made that could impact the aerosol manufacturing process or product quality. Common reasons for revalidation include:
      • Changes in the formulation (e.g., new raw materials, change in ingredient concentration)
      • Modifications to equipment or machinery (e.g., replacement, upgrade, or calibration)
      • Changes in process parameters (e.g., temperature, pressure, filling speed)
      • Corrective actions taken after process deviations or non-conformities
      • Regulatory changes that impact process requirements
    2. Any change that may affect the quality of the final product, process efficiency, or regulatory compliance should trigger the revalidation process.

    5.2. Developing the Revalidation Protocol

    1. Once the need for revalidation is identified, a revalidation protocol should be developed that outlines the following:
      • Objective: To verify that the process still meets the required product specifications after the change has been made.
      • Scope: A detailed description of the changes made and which process steps will be included in the revalidation (e.g., formulation, filling, crimping).
      • Critical Process Parameters (CPPs): The key parameters to be monitored during revalidation, including those affected by the changes made (e.g., filling volume, pressure, temperature).
      • Acceptance Criteria: Defined ranges and limits for the CPPs that must be met during revalidation (e.g., acceptable spray rate, filling accuracy, product stability).
      • Sampling Plan: The number of samples to be tested, the frequency of sampling, and the types of tests to be conducted (e.g., stability tests, chemical composition, appearance).
      • Methodology: The step-by-step process for performing revalidation, including test procedures and data recording methods.
    2. The protocol should be reviewed and approved by the QA team to ensure it aligns with GMP and regulatory requirements.

    5.3. Performing Revalidation Runs

    1. Revalidation runs should be conducted following the revalidation protocol, ensuring that all parameters are monitored and documented. Key activities include:
      • Monitoring and documenting CPPs (e.g., filling volume, spray rate, temperature, humidity)
      • Collecting quality control data (e.g., product appearance, pH, chemical composition)
      • Recording any deviations or issues during the revalidation runs
    2. All collected data should be documented in the Revalidation Data Report (Annexure-1). The report should include:
      • Batch number and production details
      • Recorded values for each monitored parameter
      • Test results and comparison to acceptance criteria
      • Any deviations and the corrective actions taken
    3. If deviations are observed, immediate corrective actions should be taken, and the process should be stopped until the root cause is identified and corrected. The Deviation Log (Annexure-2) should be completed to document the deviation and corrective actions taken.

    5.4. Reviewing Revalidation Results

    1. After the revalidation runs are complete, the QA team should review the revalidation data to ensure that all parameters meet the predefined acceptance criteria. This review should include:
      • Verification of accuracy and completeness of the revalidation records
      • Comparison of the revalidation results with the original process specifications
      • Identification of any deviations or anomalies and their potential impact on product quality
      • Confirmation that corrective actions were effective and that the process meets all quality and regulatory requirements
    2. If the revalidation results indicate that the process is not capable of meeting the required specifications, further investigation and corrective actions will be required. Revalidation may need to be repeated or adjustments made to the process to ensure compliance.

    5.5. Documenting and Reporting Revalidation Results

    1. The results of the revalidation process should be documented in a final Revalidation Report (Annexure-3). This report should include:
      • A summary of the changes made and the reasons for revalidation
      • Details of the revalidation runs, including all monitored parameters and test results
      • Any deviations or non-conformities and the corrective actions taken
      • Conclusions regarding the process’s ability to consistently meet product specifications
    2. The Revalidation Report should be reviewed and approved by the QA team and other relevant departments. Once approved, the report should be archived and stored for future reference and regulatory inspections.

    5.6. Ongoing Monitoring and Requalification

    1. If the process is successfully revalidated, ongoing monitoring should continue during routine production to ensure that it remains within acceptable limits. The following activities should be conducted regularly:
      • Periodic review of process performance
      • Requalification of equipment and processes as required
      • Continual verification that process parameters remain under control
    2. Any significant changes to the process or equipment should trigger revalidation, and the revalidation protocol should be updated accordingly.

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • CPP: Critical Process Parameter
    • CFR: Code of Federal Regulations
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Revalidation Data Report (Annexure-1)
    2. Deviation Log (Annexure-2)
    3. Revalidation Report (Annexure-3)

    8. References

    This SOP is based on the following regulatory guidelines and industry standards:

    • Good Manufacturing Practice (GMP) Guidelines
    • FDA Code of Federal Regulations (CFR) Title 21, Part 211
    • International Council for Harmonisation (ICH) Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Revalidation Data Report

    Batch Number Revalidation Date Result Remarks
    Batch-001 10/02/2025 Pass Process remains within acceptable range

    Annexure-2: Deviation Log

    Deviation ID Deviation Description Corrective Action Assigned To Status
    DEV-12345 Temperature fluctuation during filling Re-calibrated equipment Rajesh Patel Completed

    Annexure-3: Revalidation Report

    Batch Number Revalidation Date Conclusion Remarks
    Batch-001 10/02/2025 Pass Process validated successfully

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
    01/01/2025 V 2.0 Updated revalidation procedures To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
    See also  Aerosol: SOP for Conducting Valve Functionality Tests - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Tablets: SOP for Monitoring Printing Inks Used in Packaging – V 2.0
    Next Post: BA-BE Studies: SOP for Handling Serious Adverse Events (SAEs) – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version